LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD (LZAGY) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

LZAGY LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD

Watchlist

58.380
-0.280-0.48%

15min DelayTrading Nov 22 13:39 ET

42.10BMarket Cap65.08P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Lonza Group AG (LZAGY): Among UBS' Top Tech Based Disruptive Stocks For 2030
Yahoo FinanceOct 30 09:29 ET
Thermo Fisher Plant Making Astra/ Sanofi RSV Drug Reportedly Breached FDA Rules
Seeking AlphaOct 4 07:03 ET
Lonza Group AG Reports 1H Results
Seeking AlphaJul 25 10:03 ET
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand
LONZA GROUP AG UNSP ADR EACH REP 0.1 ORDJul 1 00:00 ET
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Yahoo FinanceMay 15 03:00 ET
Earnings Call Summary | LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD(LZAGY.US) Q1 2024 Earnings Conference
moomoo AIMay 14 17:31 ET · Conference Call

Comments

Moomoo News Global

Mar 4 08:15

Columns Eli Lilly's Donanemab Nears Approval Decision, Could This Be a Turning Point in Alzheimer's Treatment?

The pharma giant $Eli Lilly and Co (LLY.US)$ is on the cusp of a significant breakthrough with its Alzheimer's drug, donanemab. Following the completion of its Phase 3 trials, donanemab is currently undergoing FDA review and has the potential to receive approval later this month. If approved, it would be the second anti-Aβ therapy for Alzheimer's disease to receive full clearance from the U.S. FD...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

LZAGY LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target